# Zhejiang Haixin Zhihui Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhejiang-haixin-zhihui-technology-co

- Industry: Software
- Headquarters: Hangzhou, China
- Website: www.aistarfish.com
- Total disclosed funding: $31M
- Latest round: Series B (May 25, 2022)
- Investors on record: 6

## About

Established in 2018 and based in Hangzhou, China, Zhejiang Haixin Zhihui Technology Co., Ltd. operates as a smart medical service provider that provides tumor treatment solutions. The company reached a strategic cooperation with the Chinese Society of Clinical Oncology (csco) in March 2018. The company acquired 2019 Zhejiang science and technology small and, edium-sized enterprises in June 2020. The company obtained the national high-tech enterprise in December 2020. Yingyun is the founder of the company. The company raised CNY 200 million in series A funding.

The company provides tumor treatment solutions for patients. The company also provides cancer auxiliary diagnosis and treatment system for doctor. The company develops intelligent diagnosis and treatment system, and artificial intelligence diagnosis and treatment assistance system. The company's products include Haixin anti-cancer app. The business of the company includes CSCO AI, digital therapeutics, clinical new drugs and content operations.

The company will put the funding towards talent introduction, business expansion, the team and oncology smart business construction in series B funding.

## Funding rounds

- Series B, May 25, 2022 — Tailong VC
- Series B, Feb 21, 2022 — Qiming Venture Partners, Hepei Capital
- Series A, Dec 26, 2020, $31M — CCB International, LC Ventures, Weidu Capital

## Investors

- CCB International (https://capitalatlas.ai/funds/ccb-international) — Series A
- LC Ventures (https://capitalatlas.ai/funds/lc-ventures) — Series A
- Weidu Capital (https://capitalatlas.ai/funds/weidu-capital) — Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Hepei Capital — Series B
- Tailong VC (https://capitalatlas.ai/funds/tailong-vc) — Series B
